May Measurement Month 2019: An analysis of blood pressure screening results from Koreaopen access
- Authors
- Lee, Hae-Young; Oh, Gyu Chul; Sohn, Il Suk; Park, Sungha; Shin, Jinho; Beaney, Thoma; Partington, Giles; Poulter, Neil R.; Cho, Myeong-Chan
- Issue Date
- May-2021
- Publisher
- OXFORD UNIV PRESS
- Keywords
- Hypertension; Blood pressure; Screening; Awareness; Treatment; Control
- Citation
- EUROPEAN HEART JOURNAL SUPPLEMENTS, v.23, no.B, pp.B89 - B91
- Indexed
- SCIE
SCOPUS
- Journal Title
- EUROPEAN HEART JOURNAL SUPPLEMENTS
- Volume
- 23
- Number
- B
- Start Page
- B89
- End Page
- B91
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/182249
- DOI
- 10.1093/eurheartj/suab027
- ISSN
- 1520-765X
- Abstract
- Hypertension is the biggest contributing risk factor to cerebrovascular disease and is associated with increased risk of coronary artery disease. The May Measurement Month (MMM) campaign is a global initiative aimed at raising awareness of hypertension and acting as a temporary solution to the lack of screening programs worldwide. An opportunistic cross-sectional survey of participants aged ≥18 was carried out during May 2019 in Korea. Over 10000 participants were recruited in the MMM campaign in Korea, with a slogan of 'A simple measure to save lives #checkyourpressure'. A total of 9975 participants with valid clinical and blood pressure (BP) data were used for analysis. All participants were Korean in ethnicity, mean age was 57.2 (SD ± 21.2) years, 57.7% were females, and the mean body mass index was 23.4 kg/m2 (SD ± 3.3). In total, 37.7% of the participants reported a previous diagnosis of hypertension, and 91.3% of those diagnosed were on antihypertensive medications. For other comorbidities, 11.6% reported having diabetes mellitus, 2.0% had previous stroke, and 1.0% had previous myocardial infarction. Mean BP was 130.0/81.0 mmHg in the overall population. After multiple imputation, 47.6% of participants were classified as hypertensive (systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg or on treatment for raised BP). Among all hypertensive participants, the awareness rate, the treatment rate, and the control rate (systolic BP <140 mmHg and diastolic BP <90 mmHg) were 76.2%, 74.0%, and 50.5%, respectively. Of those on antihypertensive medication, the control rate was 68.2%. While awareness and treatment rates were relatively high in the MMM19 campaign, the BP control rate of the total hypertensive population was still only ∼50%, which demands more emphasis on strict BP control.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/182249)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.